Lancashire and South Cumbria
Formulary
Formulary
6 Endocrine system
06-07-02 Drugs affecting gonadotrophins
| Linzagolix |
|
Formulary
|
Moderate to severe symptoms of uterine fibroids.
For treating symptoms of endometriosis. |
 NICE TA1067: Linzagolix for treating symptoms of endometriosis NICE TA996: Linzagolix for treating moderate to severe symptoms of uterine fibroids |
|
| Relugolix–estradiol–norethisterone |
|
Formulary
|
For treating symptoms of endometriosis |
|
NICE TA1057: Relugolix–estradiol–norethisterone for treating symptoms of endometriosis |
|
|
| Relugolix–estradiol–norethisterone acetate Ryeqo® |
|
Formulary
|
Tablets : Estradiol (as Estradiol hemihydrate) 1 mg, Norethisterone acetate 500 microgram, Relugolix 40 mg |
|
NICE TA832: Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids |
|
|
Links
- Diabetes UK: Diabetes when you’re unwell
LSCMMG: Diabetes - Choice of Safety Pen Needles and Lancets- LSCMMG: Diabetes - Pen Needles/Lancets
- LSCMMG: Diabetes - Position Statement Safety Needles and Safety Lancets
- LSCMMG: Diabetes Guideline for antihyperglycaemic therapy in adults with type 2 diabetes
- LSCMMG: Diabetes: Recommended meters, strips and devices
LSCMMG: GLP-1 patient contract- LSCMMG: Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus
- LSCMMG: Trans Female Gender Dysphoria Information Sheet
- LSCMMG: Trans Male Gender Dysphoria Information Sheet
- LSCMMG: Triptorelin NMR
- MHRA: Diabetes and driving
- NHSE guidance to primary care about unregulated providers who supply hormone medications to children and young people for gender incongruence
- NICE HST21: Setmelanotide for treating obesity caused by LEPR or POMC deficiency
- NICE HST31: Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome
- NICE NG17: Type 1 diabetes in adults: diagnosis and management
- NICE NG18: Diabetes (type 1 and type 2) in children and young people: diagnosis and management
- NICE NG19: Diabetic foot problems: prevention and management
- NICE NG28: Type 2 diabetes in adults: management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period
- NICE TA1057: Relugolix–estradiol–norethisterone for treating symptoms of endometriosis
- NICE TA1067: Linzagolix for treating symptoms of endometriosis
- NICE TA832: Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids
- NICE TA996: Linzagolix for treating moderate to severe symptoms of uterine fibroids